8-K: AnTix Holdings Rebrands from Innovative MedTech
Corporate Name Change
Innovative MedTech, Inc. officially changed its corporate name to AnTix Holdings, Inc. effective September 19, 2025.
Summary
- The company, formerly known as Innovative MedTech, Inc., has changed its corporate name to AnTix Holdings, Inc.
- The Certificate of Amendment to the Amended and Restated Certificate of Incorporation was filed with the State of Delaware on September 19, 2025.
- Common stock will continue to trade under the ticker symbol IMTH for the time being.
- AnTix Holdings, Inc. intends to file with FINRA to effectuate a change in its ticker symbol from IMTH to a new symbol.
- Outstanding stock certificates for shares of the company remain valid and do not require exchange at this time.
Sentiment
Score: 5
Explanation: The filing reports an administrative corporate name change, which is a neutral event in itself. No financial or operational performance details are provided to indicate a positive or negative sentiment.
Future Outlook
The company intends to file with FINRA to change its ticker symbol from IMTH to a new, as yet undisclosed, ticker symbol.
Management Comments
- Michael Jordan Friedman, President, Chief Executive Officer and Member of the Board of Directors, signed the report on behalf of AnTix Holdings, Inc.
Industry Context
A corporate name change can sometimes signal a strategic pivot or a re-focusing of business operations within an industry. However, this filing does not provide specific details regarding the strategic rationale behind the name change, making it difficult to assess its broader industry implications without further information.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Articles of Incorporation | Amendment to the Amended and Restated Certificate of Incorporation to change the corporate name from Innovative MedTech, Inc. to AnTix Holdings, Inc. | 2025-09-19 | This is an administrative change to the company's legal identity. It does not immediately alter the company's operational structure, financial obligations, or shareholder rights, though it may precede or reflect strategic shifts. |
Stakeholder Impact
- Shareholders: Existing stock certificates remain valid and do not require exchange. The change in corporate name and future ticker symbol may require shareholders to update their records or be aware of the new identity for trading purposes.
- Customers/Suppliers: May need to update their records to reflect the new corporate name for invoicing, contracts, and communications.
Next Steps
- File with FINRA to effectuate the change of the ticker symbol from IMTH to a new symbol.
Key Dates
| Date | Description |
|---|---|
| 2025-09-19 | Certificate of Amendment to Amended and Restated Certificate of Incorporation filed with the State of Delaware, changing the corporate name from Innovative MedTech, Inc. to AnTix Holdings, Inc. |
| 2025-09-29 | Date the 8-K report was signed by Michael Jordan Friedman, President, Chief Executive Officer and Member of the Board of Directors. |
Recommendation
holdThe filing reports an administrative corporate name change with no immediate financial or operational impact disclosed. It does not provide new information to warrant a change in investment recommendation, thus a 'hold' stance is appropriate until further strategic or financial details are released.
Keywords
AnTix Holdings, Innovative MedTech, name change, corporate rebranding, IMTH, ticker symbol, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.